Drug Trials Snapshot: LUMAKRAS (SOTORASIB)

LUMAKRAS is a drug used to treat adult patients with non-small cell lung cancer (NSCLC) that is locally advanced or has spread to other parts of the body (metastatic). It should be used in patients who have been treated with at least one prior type of therapy and whose cancer has a certain type of genetic mutation (KRAS G12C). https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshot-lumakras